European Stocks Rally on Pharma Shakeups, Tech Surge – What’s Next?
On Monday, Europe’s stock markets built on last week’s Fed-inspired optimism. Investors cheered a mix of corporate news and the prospect of more US rate cuts. Britain’s FTSE 100 climbed roughly 0.5%, putting it near record highs, and the STOXX 600 closed about +0.2% reuters.com. France’s CAC 40 and Germany’s DAX each gained a few tenths of a percent reuters.com. Major indices in Southern Europe also edged up. Across sectors, the strongest gains were in healthcare and tech, offsetting weakness in commodity-linked areas and automakers. Several high-profile company announcements drove individual stocks on Monday. In pharmaceuticals, GSK jumped ~3.5% after announcing that long-time CEO Emma Walmsley will step down at year-end, handing over to COO Luke Miels reuters.com. A market commentator noted GSK shares had been lagging peers, and the new leadership “is a bet the market likes for now” standard.co.uk. AstraZeneca also moved higher when it said it will list ordinary shares directly in New York to attract more US investors, while keeping its London and Stockholm listings reuters.com. CEO Pascal Soriot and CFO Chris Demarest emphasized the change “will allow us to reach a broader mix of global investors” reuters.com.
